Microbial Solutions Facility: Singapore

Our Microbial Solutions site in Singapore offers a progressive portfolio of quality control testing solutions for the pharmaceutical, medical device, and consumer care industries to help bring products to market safely and efficiently.

 Get in Touch

dublin ireland microbial solutions facility manager

Explore Our Singapore Facility

Our products and services are designed to streamline workflows and supply chains, ensure the integrity of test data, and allow you to release products with the confidence of total quality control.

Site Background

  • Founded in 1997 as BRASS Pte Ltd
  • Acquired by Charles River in 2013
  • Serves a range of customers from start-ups to large industry leaders in the pharmaceutical, microbiological, ATMP, and medical device space
  • Approximately 30 employees

Laboratories and Facilities

  • 1297 m2 / 13,962 sq. ft. of office space, training suites, microbiology and application development labs

Compliance, Certifications, Accreditations, and Professional Affiliations

The Microbial Solutions Singapore facility operates in compliance with the following regulatory agencies or accredited organizations: 

  • ISO 9001
  • ISO/IEC 17025 [A2LA accreditation for microbiological services]
  • ISO 17025 [A2LA accreditation for Accugenix® microbial identification]

Product and Service Offerings

Product/ServiceDescription
Endosafe® Endotoxin Testing
Celsis® Rapid Microbial Contamination Detection
Accugenix® Microbial Identification
Additional Services
  • Microbial enumeration & specified microorganism detection
  • Antimicrobial effectiveness and disinfectant efficacy qualification testing
  • Sterilization validation support
  • Sterility and bioburden testing
  • Custom test method development
  • Mycoplasma and Spiroplasma Detection (RT-PCR)

3Rs: Replace, Reduce, Refine

We embrace the commitment to advance responsible science through the 3Rs to help lead and collaborate on the progressive pursuit within the industry regarding animal welfare.

  • Replacement: Endosafe® Trillium™ is a robust, recombinant cascade reagent that does not use horseshoe crab blood for the source materials, or any other animal derived products, further strengthening our commitment.
  • Reduction: For over 20 years, our flagship Endosafe® LAL Cartridge Technology has allowed us to optimize our resources and refine our formulation while reducing our reliance on the horseshoe crab by eliminating 95% of the raw material via microfluidic technology.
  • Refinement: Our R&D team continues to challenge and optimize our LAL formulation to introduce creative techniques and methods to utilize less raw material from the horseshoe crab. 

Download Facility Sheet

Contact Information

33 Ubi Avenue 3,
#06-17/18 Vertex (Tower B),
Singapore 408868
P: +65-6742 6007
Email: [email protected]